ResearcherUniversity of California, Los AngelesNo recent work listed

Dimitrios Iliopoulos

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6832-0786; OpenAlex author ID A5101843028. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2016: 1 paper

Papers 1

Transcriptomic and CRISPR/Cas9 technologies reveal FOXA2 as a tumor suppressor gene in pancreatic cancer. Last author DOI 10.1152/ajpgi.00035.2016 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Timothy R. Donahue · 1 shared paper, 2016 · strength 0.06
- Paper Transcriptomic and CRISPR/Cas9 technologies reveal FOXA2 as a tumor suppressor gene in pancreatic cancer. DOI 10.1152/ajpgi.00035.2016 ↗
George A. Poultsides · 1 shared paper, 2016 · strength 0.06
- Paper Transcriptomic and CRISPR/Cas9 technologies reveal FOXA2 as a tumor suppressor gene in pancreatic cancer. DOI 10.1152/ajpgi.00035.2016 ↗
Christina Vorvis · 1 shared paper, 2016 · strength 0.06
- Paper Transcriptomic and CRISPR/Cas9 technologies reveal FOXA2 as a tumor suppressor gene in pancreatic cancer. DOI 10.1152/ajpgi.00035.2016 ↗
Maria Hatziapostolou · 1 shared paper, 2016 · strength 0.06
- Paper Transcriptomic and CRISPR/Cas9 technologies reveal FOXA2 as a tumor suppressor gene in pancreatic cancer. DOI 10.1152/ajpgi.00035.2016 ↗
Guido Eibl · 1 shared paper, 2016 · strength 0.06
- Paper Transcriptomic and CRISPR/Cas9 technologies reveal FOXA2 as a tumor suppressor gene in pancreatic cancer. DOI 10.1152/ajpgi.00035.2016 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.